TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways

[1]  D. Schreiner,et al.  Specification of CNS macrophage subsets occurs postnatally in defined niches , 2022, Nature.

[2]  Evan Z. Macosko,et al.  Dissection of artifactual and confounding glial signatures by single-cell sequencing of mouse and human brain , 2022, Nature Neuroscience.

[3]  Tau En Lim,et al.  Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer’s disease , 2021, Molecular neurodegeneration.

[4]  M. Colonna,et al.  Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice? , 2021, The Journal of experimental medicine.

[5]  Anonymous,et al.  2021 Alzheimer's disease facts and figures , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[6]  Melanie A. Huntley,et al.  Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology , 2021, Neuron.

[7]  Adam P. Silverman,et al.  APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function , 2021, Science Translational Medicine.

[8]  M. Simons,et al.  White matter aging drives microglial diversity , 2021, Neuron.

[9]  F. Quintana,et al.  Microglia and Central Nervous System-Associated Macrophages-From Origin to Disease Modulation. , 2021, Annual review of immunology.

[10]  M. van Lookeren Campagne,et al.  Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer’s disease , 2021, Proceedings of the National Academy of Sciences.

[11]  Helena L. Crowell,et al.  muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data , 2020, Nature Communications.

[12]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[13]  Maxim N. Artyomov,et al.  TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy , 2020, Cell.

[14]  H. Rhinn,et al.  Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model , 2020, The Journal of experimental medicine.

[15]  F. Ginhoux,et al.  Early Fate Defines Microglia and Non-parenchymal Brain Macrophage Development , 2020, Cell.

[16]  Steve Lianoglou,et al.  TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.

[17]  Maxim N. Artyomov,et al.  Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and - independent cellular responses in Alzheimer’s disease , 2019, Nature Medicine.

[18]  Hailan Yao,et al.  Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities , 2019, Front. Cell. Neurosci..

[19]  D. Holtzman,et al.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies , 2019, Cell.

[20]  Chao Zhang,et al.  Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model , 2019, Nature Communications.

[21]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[22]  Hector Roux de Bézieux,et al.  Trajectory-based differential expression analysis for single-cell sequencing data , 2019, Nature Communications.

[23]  Nicola Thrupp,et al.  The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques , 2019, Cell reports.

[24]  F. Ginhoux,et al.  Microglia and early brain development: An intimate journey , 2018, Science.

[25]  M. Colonna,et al.  TREM2 — a key player in microglial biology and Alzheimer disease , 2018, Nature Reviews Neurology.

[26]  M. Colonna,et al.  Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism , 2018, The Journal of experimental medicine.

[27]  Huaxi Xu,et al.  TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function , 2018, Neuron.

[28]  Melanie A. Huntley,et al.  Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer's Disease Not Evident in Mouse Models. , 2018, Cell reports.

[29]  A. Regev,et al.  Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution , 2017, Cell reports.

[30]  Markus Glatzel,et al.  The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. , 2017, Immunity.

[31]  M. Rosenblum,et al.  A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease , 2017, Nature.

[32]  Maxim N. Artyomov,et al.  TREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease , 2017, Cell.

[33]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[34]  Russell B. Fletcher,et al.  Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics , 2017, BMC Genomics.

[35]  Tuan Leng Tay,et al.  A new fate mapping system reveals context-dependent random or clonal expansion of microglia , 2017, Nature Neuroscience.

[36]  R. Ransohoff,et al.  Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease , 2017, The Journal of Neuroscience.

[37]  O. Garaschuk,et al.  Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain , 2017, Cell reports.

[38]  L. Gan,et al.  Targeting microglia for the treatment of Alzheimer's Disease , 2016, Glia.

[39]  Lino C. Gonzalez,et al.  TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.

[40]  J. Grutzendler,et al.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy , 2016, Neuron.

[41]  S. Linnarsson,et al.  Origin, fate and dynamics of macrophages at central nervous system interfaces , 2016, Nature Immunology.

[42]  D. Holtzman,et al.  TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques , 2016, The Journal of experimental medicine.

[43]  S. Younkin,et al.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.

[44]  D. Holtzman,et al.  TREM2 lipid sensing sustains microglia response in an Alzheimer’s disease model , 2015, Cell.

[45]  J. Grutzendler,et al.  Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques , 2014, Nature Communications.

[46]  F. Geissmann,et al.  Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.

[47]  T. Luedde,et al.  A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation , 2013, Nature Neuroscience.

[48]  D. Gutmann,et al.  Motivational Disturbances and Effects of L-dopa Administration in Neurofibromatosis-1 Model Mice , 2013, PloS one.

[49]  A. Mildner,et al.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.

[50]  L. Mucke,et al.  Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. , 2012, Cold Spring Harbor perspectives in medicine.

[51]  D. Selkoe,et al.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[52]  J. Pollard,et al.  A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells , 2012, Science.

[53]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[54]  K. Coggeshall,et al.  TREM2- and DAP12-Dependent Activation of PI3K Requires DAP10 and Is Inhibited by SHIP1 , 2010, Science Signaling.

[55]  C. Chu,et al.  The expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells , 2009, Immunological reviews.

[56]  L. Lanier.  DAP10‐ and DAP12‐associated receptors in innate immunity , 2009, Immunological reviews.

[57]  M. Freeman,et al.  Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling , 2008, Nature.

[58]  Hideaki Nakajima,et al.  Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. , 2008, Blood.

[59]  A. Mócsai,et al.  Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs , 2006, Nature Immunology.

[60]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[61]  D. Underhill,et al.  Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. , 2005, Blood.

[62]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  S. Gordon,et al.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.

[64]  S. Gordon,et al.  Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. , 2004, Blood.

[65]  Maureen P. Boyle,et al.  Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults , 2004, Neurobiology of Disease.

[66]  Joseph H. Phillips,et al.  Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200 1 , 2003, The Journal of Immunology.

[67]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[68]  A. Tarakhovsky,et al.  Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development , 2003, Nature Immunology.

[69]  M. Colonna,et al.  NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation , 2002, Nature Immunology.

[70]  Siamon Gordon,et al.  Dectin-1 Is A Major β-Glucan Receptor On Macrophages , 2002, The Journal of experimental medicine.

[71]  H. Eldar-Finkelman,et al.  Glycogen synthase kinase 3: an emerging therapeutic target. , 2002, Trends in molecular medicine.

[72]  J. Ortaldo,et al.  Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. , 2000, Immunity.

[73]  J. D. Di Santo,et al.  Tyrosine kinase SYK: essential functions for immunoreceptor signalling. , 2000, Immunology today.

[74]  A. Weiss,et al.  The Syk family of protein tyrosine kinases in T‐cell activation and development , 1998, Immunological reviews.